Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.
Jung HA, Lim J, Choi YL, Lee SH, Joung JG, Jeon YJ, Choi JW, Shin S, Cho JH, Kim HK, Choi YS, Zo JI, Shim YM, Park S, Sun JM, Ahn JS, Ahn MJ, Han J, Park WY, Kim J, Park K.
Jung HA, et al. Among authors: choi jw, choi ys, choi yl.
Clin Cancer Res. 2022 Oct 3;28(19):4312-4321. doi: 10.1158/1078-0432.CCR-22-0879.
Clin Cancer Res. 2022.
PMID: 35838647